N-[[1-(2,4-dimethoxybenzoyl)piperidin-4-yl]methyl]-N-[(E)-2-methyl-3-phenylprop-2-enyl]cyclohexanecarboxamide

C32H42N2O4 — CID 42705625

IUPACN-[[1-(2,4-dimethoxybenzoyl)piperidin-4-yl]methyl]-N-[(E)-2-methyl-3-phenylprop-2-enyl]cyclohexanecarboxamide
SMILESCOc1ccc(C(=O)N2CCC(CN(C/C(C)=C/c3ccccc3)C(=O)C3CCCCC3)CC2)c(OC)c1
InChIInChI=1S/C32H42N2O4/c1-24(20-25-10-6-4-7-11-25)22-34(31(35)27-12-8-5-9-13-27)23-26-16-18-33(19-17-26)32(36)29-15-14-28(37-2)21-30(29)38-3/h4,6-7,10-11,14-15,20-21,26-27H,5,8-9,12-13,16-19,22-23H2,1-3H3/b24-20+
InChIKeyDGWZGCPYKCAZMY-HIXSDJFHSA-N
MW518.70 g/mol
LogP6.07
Rot. Bonds9

About N-[[1-(2,4-dimethoxybenzoyl)piperidin-4-yl]methyl]-N-[(E)-2-methyl-3-phenylprop-2-enyl]cyclohexanecarboxamide

N-[[1-(2,4-dimethoxybenzoyl)piperidin-4-yl]methyl]-N-[(E)-2-methyl-3-phenylprop-2-enyl]cyclohexanecarboxamide (PubChem CID 42705625) has the molecular formula C32H42N2O4 and a molecular weight of 518.70 g/mol. Its IUPAC name is N-[[1-(2,4-dimethoxybenzoyl)piperidin-4-yl]methyl]-N-[(E)-2-methyl-3-phenylprop-2-enyl]cyclohexanecarboxamide.

Molecular Properties

Compound NameN-[[1-(2,4-dimethoxybenzoyl)piperidin-4-yl]methyl]-N-[(E)-2-methyl-3-phenylprop-2-enyl]cyclohexanecarboxamide
PubChem CID42705625
Molecular FormulaC32H42N2O4
Molecular Weight518.70 g/mol
Exact Mass518.31
IUPAC NameN-[[1-(2,4-dimethoxybenzoyl)piperidin-4-yl]methyl]-N-[(E)-2-methyl-3-phenylprop-2-enyl]cyclohexanecarboxamide
SMILESCOc1ccc(C(=O)N2CCC(CN(C/C(C)=C/c3ccccc3)C(=O)C3CCCCC3)CC2)c(OC)c1
InChIInChI=1S/C32H42N2O4/c1-24(20-25-10-6-4-7-11-25)22-34(31(35)27-12-8-5-9-13-27)23-26-16-18-33(19-17-26)32(36)29-15-14-28(37-2)21-30(29)38-3/h4,6-7,10-11,14-15,20-21,26-27H,5,8-9,12-13,16-19,22-23H2,1-3H3/b24-20+
InChIKeyDGWZGCPYKCAZMY-HIXSDJFHSA-N
XLogP6.07
TPSA59.08 Ų
H-Bond Donors
H-Bond Acceptors4
Rotatable Bonds9
Heavy Atoms38
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500518.70
LogP ≤ 56.07
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 104

Analyze N-[[1-(2,4-dimethoxybenzoyl)piperidin-4-yl]methyl]-N-[(E)-2-methyl-3-phenylprop-2-enyl]cyclohexanecarboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[[1-(2,4-dimethoxybenzoyl)piperidin-4-yl]methyl]-N-[(E)-2-methyl-3-phenylprop-2-enyl]cyclohexanecarboxamide?
The IUPAC name of N-[[1-(2,4-dimethoxybenzoyl)piperidin-4-yl]methyl]-N-[(E)-2-methyl-3-phenylprop-2-enyl]cyclohexanecarboxamide (CID 42705625) is N-[[1-(2,4-dimethoxybenzoyl)piperidin-4-yl]methyl]-N-[(E)-2-methyl-3-phenylprop-2-enyl]cyclohexanecarboxamide.
What is the SMILES notation for N-[[1-(2,4-dimethoxybenzoyl)piperidin-4-yl]methyl]-N-[(E)-2-methyl-3-phenylprop-2-enyl]cyclohexanecarboxamide?
The canonical SMILES for N-[[1-(2,4-dimethoxybenzoyl)piperidin-4-yl]methyl]-N-[(E)-2-methyl-3-phenylprop-2-enyl]cyclohexanecarboxamide is COc1ccc(C(=O)N2CCC(CN(C/C(C)=C/c3ccccc3)C(=O)C3CCCCC3)CC2)c(OC)c1.
What is the InChIKey of N-[[1-(2,4-dimethoxybenzoyl)piperidin-4-yl]methyl]-N-[(E)-2-methyl-3-phenylprop-2-enyl]cyclohexanecarboxamide?
The InChIKey is DGWZGCPYKCAZMY-HIXSDJFHSA-N. The full InChI is InChI=1S/C32H42N2O4/c1-24(20-25-10-6-4-7-11-25)22-34(31(35)27-12-8-5-9-13-27)23-26-16-18-33(19-17-26)32(36)29-15-14-28(37-2)21-30(29)38-3/h4,6-7,10-11,14-15,20-21,26-27H,5,8-9,12-13,16-19,22-23H2,1-3H3/b24-20+.
What are the key properties of N-[[1-(2,4-dimethoxybenzoyl)piperidin-4-yl]methyl]-N-[(E)-2-methyl-3-phenylprop-2-enyl]cyclohexanecarboxamide?
N-[[1-(2,4-dimethoxybenzoyl)piperidin-4-yl]methyl]-N-[(E)-2-methyl-3-phenylprop-2-enyl]cyclohexanecarboxamide has a molecular weight of 518.70 g/mol, XLogP of 6.07, 9 rotatable bonds, 0 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[1-(2,4-dimethoxybenzoyl)piperidin-4-yl]methyl]-N-[(E)-2-methyl-3-phenylprop-2-enyl]cyclohexanecarboxamide is sourced from PubChem (CID 42705625), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).